U.S. FDA authorizes Pfizer's COVID-19 booster for 12- to 15-year-olds
The agency also shortened the time between the completion of primary vaccination of the Pfizer-BioNTech COVID-19 vaccine and a booster dose to five months from six.
Pfizer
![The agency also shortened the time between the completion of primary vaccination of the Pfizer-BioNTech COVID-19 vaccine and a booster dose to five months from six.]()
U.S. authorizes Pfizer oral COVID-19 treatment, first for at-home use
Data from Pfizer’s clinical trial showed two-drug antiviral regimen was 90% effective in preventing hospitalizations and deaths in high-risk patients
![Pfizer's Covid-19 Paxlovid pills]()
Pfizer, AstraZeneca COVID vaccines less effective at fighting Omicron: study
Pfizer jabs protect 70% against hospitalization from omicron
![Pfizer, AstraZeneca COVID vaccines less effective at fighting Omicron: study]()
US authorises Pfizer, Moderna boosters
CDC Director Rochelle Walensky signed off on the booster shots hours after the agency’s independent panel of vaccine scientists unanimously endorsed opening up eligibility to everyone 18 and older at least six months after they received their second dose.
![US authorises Pfizer, Moderna boosters]()
Pfizer to allow generic versions of its COVID pill in 95 countries
Pfizer said on Tuesday it will allow generic manufacturers to supply its experimental antiviral COVID-19 pill to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool.
![Pfizer to allow generic versions of its COVID pill in 95 countries]()
Pfizer says antiviral pill cuts risk of severe COVID-19 by 89%
The results appear to surpass those seen with Merck & Co Inc's pill, molnupiravir
![Pfizer says antiviral pill cuts risk of severe COVID-19 by 89%]()
Pfizer on track for U.S. vaccine boosters, Moderna lagging, Fauci says
Last month the Biden administration announced it would start offering boosters to Americans by Sept. 20, usurping the process by which the FDA and the U.S. Centers for Disease Control and Prevention usually decide on such issues, current and former FDA scientists and CDC advisory panel members have told Reuters.
![Pfizer on track for U.S. vaccine boosters, Moderna lagging, Fauci says]()
Pfizer, BioNTech to seek authorization for COVID booster shot as Delta variant spreads
Pfizer and partner BioNTech plan to ask U.S. and European regulators within weeks to authorize a booster dose of its COVID-19 vaccine, based on evidence of greater risk of infection six months after inoculation and the spread of the highly contagious Delta variant.
![Pfizer, BioNTech to seek authorization for COVID booster shot as Delta variant spreads]()
